Skip Navigation



NDT Advance Access published online on December 29, 2005

Nephrology Dialysis Transplantation, doi:10.1093/ndt/gfk008
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
21/4/911    most recent
gfk008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Mizobuchi, M.
Right arrow Articles by Akizawa, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Mizobuchi, M.
Right arrow Articles by Akizawa, T.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author [2005]. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org
Received December 21, 2004
Accepted November 28, 2005


Original Article

Up-regulation of Cbfa1 and Pit-1 in calcified artery of uraemic rats with severe hyperphosphataemia and secondary hyperparathyroidism

Masahide Mizobuchi 1, Hiroaki Ogata 2 *, Ikuji Hatamura 3, Fumihiko Koiwa 4, Fumie Saji 1, Kazuhiro Shiizaki 1, Shigeo Negi 1, Eriko Kinugasa 2, Akira Ooshima 3, Shozo Koshikawa 4, and Tadao Akizawa 1

1 Center of Blood Purification Therapy, Wakayama Medical University, Wakayama, Japan
2 Department of Internal Medicine, Showa University Northern Yokohama Hospital, Yokohama, Japan
3 First Department of Pathology, Wakayama Medical University, Wakayama, Japan
4 Division of Nephrology, Department of Internal Medicine, Showa University Fujigaoka Hospital, Yokohama, Japan

* To whom correspondence should be addressed.
Hiroaki Ogata, E-mail: ogatah{at}med.showa-u.ac.jp



  Abstract

Background. Cardiovascular disease is the most frequent cause of death in patients with end-stage kidney disease (ESKD). Vascular calcification is a confirmed risk factor for cardiovascular events in the general population and has a high occurrence in patients with ESKD. Despite the high prevalence of vascular calcification in ESKD, the pathogenesis of the disorder is still obscure. The present study examined the expressions of bone-associated factors in calcified arteries in subtotally nephrectomized rats with severe secondary hyperparathyroidism (SHPT).

Methods. Seven-week-old male Sprague-Dawley rats were divided into five groups as follows: sham-operated rats that received a normal diet [0.8% of phosphorus (P), 1.1% of calcium (Ca)] (Sham), sham-operated rats that received a high-phosphorus and low-calcium (HPLCa) diet (1.2% P, 0.4% Ca) (Sham+HPLCa), 5/6 nephrectomized rats that received a normal diet as the uraemic control group (Nx), and 5/6 nephrectomized rats that received a HPLCa diet to induce the development of SHPT (Nx+HPLCa), and 5/6 nephrectomized and parathyroidectomized rats that received a HPLCa diet (Nx+PTx+HPLCa). The feeding period of each group was 10 weeks. The rats were then sacrificed and their serum was examined. The upper part of the abdominal aorta was used to investigate the expression of mRNAs of core-binding factor alpha-1 (Cbfa1) and sodium-dependent phosphate cotransporter (Pit-1) by real-time reverse transcriptase polymerase chain reaction (real-time PCR) analysis. The lower part was examined for calcification by von Kossa staining.

Results. Serum P level and Ca x P products increased significantly in the Nx+HPLCa group compared with those of any other groups. Severe hyperparathyroidism was also observed in the Nx+HPLCa group. Vascular calcification (medial layer) was observed in the Nx+HPLCa group only. There was a significant increase in Cbfa1 and Pit-1 mRNA expression levels in the aorta of the Nx+HPLCa group compared with that of any other groups.

Conclusions. These results suggest that medial layer vascular calcification in uraemic rats with severe hyperphosphataemia and SHPT may be caused in part by Cbfa1 and Pit-1.

Keywords: core-binding factor alpha-1 (Cbfa1); hyperphosphataemia; secondary hyperparathyroidism (SHPT); sodium-dependent phosphate cotransporter (Pit-1); vascular calcification.
Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Am. Soc. Nephrol.Home page
M. Mizobuchi, D. Towler, and E. Slatopolsky
Vascular Calcification: The Killer of Patients with Chronic Kidney Disease
J. Am. Soc. Nephrol., July 1, 2009; 20(7): 1453 - 1464.
[Abstract] [Full Text] [PDF]


Home page
Nephrol Dial TransplantHome page
A. Adijiang, S. Goto, S. Uramoto, F. Nishijima, and T. Niwa
Indoxyl sulphate promotes aortic calcification with expression of osteoblast-specific proteins in hypertensive rats
Nephrol. Dial. Transplant., June 1, 2008; 23(6): 1892 - 1901.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
L. V. Virkki, J. Biber, H. Murer, and I. C. Forster
Phosphate transporters: a tale of two solute carrier families
Am J Physiol Renal Physiol, September 1, 2007; 293(3): F643 - F654.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
S. Ravera, L. V. Virkki, H. Murer, and I. C. Forster
Deciphering PiT transport kinetics and substrate specificity using electrophysiology and flux measurements
Am J Physiol Cell Physiol, August 1, 2007; 293(2): C606 - C620.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
R. Villa-Bellosta, Y. E. Bogaert, M. Levi, and V. Sorribas
Characterization of Phosphate Transport in Rat Vascular Smooth Muscle Cells: Implications for Vascular Calcification
Arterioscler Thromb Vasc Biol, May 1, 2007; 27(5): 1030 - 1036.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
R. C. Johnson, J. A. Leopold, and J. Loscalzo
Vascular Calcification: Pathobiological Mechanisms and Clinical Implications
Circ. Res., November 10, 2006; 99(10): 1044 - 1059.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.